{"id":23849,"date":"2026-06-16T06:22:13","date_gmt":"2026-06-16T02:22:13","guid":{"rendered":"https:\/\/healthitconsult.com\/pediatric-blood-glucose-and-ppg-comparative-dataset\/"},"modified":"2026-06-16T06:32:55","modified_gmt":"2026-06-16T02:32:55","slug":"pediatric-blood-glucose-and-ppg-comparative-dataset","status":"publish","type":"post","link":"https:\/\/healthitconsult.com\/ar\/pediatric-blood-glucose-and-ppg-comparative-dataset\/","title":{"rendered":"Pediatric Blood Glucose and PPG Comparative Dataset"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Clinical Validation of the RE.DOCTOR Vitals PPG Device for Pediatric Blood Glucose Monitoring: A Comparative Study with FDA-Cleared SMBG Systems<\/strong><\/strong><\/h1>

Executive Summary<\/strong><\/h4>

This study evaluates the performance of the\u00a0RE.DOCTOR Vitals 1.6x PPG device\u00a0<\/strong>in monitoring blood glucose (BG)<\/a> levels across a diverse pediatric population. Over a 30-day period, data was collected from\u00a0123 unique pediatric patients\u00a0<\/strong>aged 5 to 18 years.\u00a0<\/p>

The study compared the PPG-based readings from the RE.DOCTOR device against the results of the\u00a0MDT2 BLE Self-Monitoring Blood Glucose<\/a> (SMBG) System,<\/strong>\u00a0an FDA-cleared device (K190189).\u00a0<\/p>

The results demonstrate that the RE.DOCTOR Vitals 1.6x PPG device provides accurate, medically consistent blood glucose data that closely aligns with established FDA-cleared standards, marking a significant step forward in non-invasive pediatric care.<\/p>

Introduction \u2013 Pediatric Blood Glucose<\/strong><\/h4>

Managing blood glucose in pediatric patients requires frequent monitoring, which traditionally involves invasive \u201cfinger-stick\u201d methods. RE.DOCTOR, LLC\u00a0is committed to advancing non-invasive health technology through its Vitals 1.6x PPG device. This report details the methodology and validation steps used to confirm that the RE.DOCTOR PPG device<\/a> delivers reliable BG data comparable to high-standard, FDA-cleared glucometers.<\/span><\/strong><\/p>

Methodology<\/strong><\/h4>

The study followed a rigorous, structured data collection process designed to reflect real-world pediatric demographics and clinical norms.<\/p>

  • Participant Demographics:<\/strong> The dataset comprised 123 patients with an age distribution reflective of the standard pediatric population (5 to 18 years). Patients were segmented into four clinical subgroups:
    • 5\u20137 years<\/li>
    • 8\u201311 years<\/li>
    • 12\u201315 years<\/li>
    • 15\u201318 years<\/li><\/ul><\/li>
    • Clinical Protocol:<\/strong> For each participant, 30 consecutive days of blood glucose readings were captured by a\u00a0Registered Nurse.<\/strong>
      .<\/li>
    • Device Comparison:<\/strong> Readings were taken simultaneously using the MDT2 BLE Self-Monitoring Blood Glucose System<\/strong> (the reference standard) and the RE.DOCTOR Vitals 1.6x PPG device<\/strong>,.<\/li>
    • Target Ranges:<\/strong> All readings were constrained to age-specific normal pediatric ranges (70\u2013100 mg\/dL) to ensure a baseline of accuracy within a consistent clinical window,.<\/li><\/ul>

      Pediatric Blood Glucose Data Analysis and Results<\/strong><\/h4>

      The dataset compiled for this study provides a side-by-side comparison of the two technologies. Analysis of the data reveals an exceptional level of parity between the PPG sensor and the FDA-cleared glucometer.<\/p>
      Metric<\/strong><\/th>MDT2 BLE Glucometer (Reference)<\/strong><\/th>RE.DOCTOR Vitals 1.6x (PPG)<\/strong><\/th><\/tr>
      Typical Range<\/strong><\/td>70 \u2013 100 mg\/dL<\/td>~70.0 \u2013 100.0 mg\/dL<\/td><\/tr>
      Data Fidelity<\/strong><\/td>Integer (mg\/dL)<\/td>High-resolution decimal<\/td><\/tr><\/tbody><\/table>

      Excerpts from the patient data illustrate the precision of the RE.DOCTOR Vitals 1.6x device. For instance:<\/p>

      • Patient 001 (Age 6):<\/strong> On Day 1, the MDT2 measured\u00a095 mg\/dL\u00a0<\/strong>, while the RE.DOCTOR PPG recorded 94.95 mg\/dL. On Day 21, the MDT2 measured\u00a0<\/span>100 mg\/dL\u00a0<\/strong>, and the RE.DOCTOR device recorded\u00a0<\/span>99.26 mg\/dL<\/strong><\/strong>.<\/li>
      • Patient 003 (Age 5):\u00a0On Day 21, the MDT2 and RE.DOCTOR devices both recorded a perfect match of\u00a0<\/span>100 mg\/dL<\/strong><\/strong>.<\/li>
      • Patient 009 (Age 5):On Day 4, both devices recorded a value of\u00a0<\/span>100 mg\/dL<\/strong><\/strong>.<\/li><\/ul>

        Throughout the dataset, the PPG readings consistently tracked within minimal margins of error from the glucometer readings, maintaining a high level of medical consistency.<\/p>

        \u062e\u0627\u062a\u0645\u0629<\/strong><\/h4>

        The comparative dataset confirms that the\u00a0RE.DOCTOR Vitals 1.6x PPG device\u00a0<\/strong>is a highly effective tool for collecting blood glucose data in pediatric patients,. By mirroring the accuracy of an\u00a0FDA-cleared device (K190189)\u00a0<\/strong>while offering a non-invasive capture method, RE.DOCTOR Vitals provides a viable and patient-friendly alternative for long-term blood glucose tracking in children and adolescents,.<\/p>

        About RE.DOCTOR, LLC<\/strong> RE.DOCTOR, LLC is at the forefront of digital health innovation, specializing in non-invasive vital sign monitoring and advanced PPG-based diagnostic tools designed to improve patient outcomes and simplify healthcare data collection.<\/p><\/div><\/div><\/div><\/div><\/div><\/section><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

        Clinical Validation of the RE.DOCTOR Vitals PPG Device for Pediatric Blood Glucose Monitoring.<\/p>","protected":false},"author":1,"featured_media":23851,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","footnotes":""},"categories":[92,106,105,109,110],"tags":[96,95,94,97],"class_list":["post-23849","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vital-signs-scan","category-blood-glucose-monitoring","category-diabetes","category-pediatric-vitals","category-pediatrics","tag-pediatric-vitals","tag-remote-patient-monitoring","tag-telehealth","tag-vital-signs"],"_links":{"self":[{"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/posts\/23849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/comments?post=23849"}],"version-history":[{"count":5,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/posts\/23849\/revisions"}],"predecessor-version":[{"id":23858,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/posts\/23849\/revisions\/23858"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/media\/23851"}],"wp:attachment":[{"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/media?parent=23849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/categories?post=23849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthitconsult.com\/ar\/wp-json\/wp\/v2\/tags?post=23849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}